Exisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Trademark by OSI Pharmaceuticals is Aptosyn. NCBI PubChem ID 5472495. Also listed as Sulindac sulfone which is a metabolic product of Sulindac (see).
This page contains content from the copyrighted Wikipedia article "Exisulind"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
